RxDoctor Payments Data

Hanna Percy

Nurse Practitioner · Pocatello, IDNPI 1225687759

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,252 of the $6,390 with a category attached, or 66.5%. It is spread thinly across 27 manufacturers, the largest accounting for just 20.7%. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,390in general payments, 2019–2025

Across 235 payments — averaging $27.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Enterra Medical, Inc.$1K
  • AbbVie$1K
  • Intuitive Surgical$1K
  • Bristol Myers Squibb$404
  • Takeda Pharmaceuticals U.S.A., Inc.$319
  • Pfizer$283
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$2,13833%
  • Food & beverage$4,25267%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,390 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$13,213
Medicare patients
71
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase20$60,394
ZenpepLipase/Protease/Amylase15$46,952
LinzessLinaclotide30$18,426
VoqueznaVonoprazan Fumarate12$7,612
TrulancePlecanatide12$7,099
Budesonide DrBudesonide15$2,346
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates16$1,197
Pantoprazole Sodium91$1,140
Esomeprazole Magnesium20$998
Famotidine72$765
Omeprazole63$744
Metoclopramide Hcl14$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,287$78,82050 claims
Aimmune Therapeutics, Inc.Zenpep$103$46,95215 claims
Phathom Pharmaceuticals, Inc.Voquezna$174$7,61212 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$157$7,09912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 570 nurse practitioner providers in Idaho.

Other nurse practitioner in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →